Analysis of 260,000 pediatric test results over 42 months revealed that relying on single-pathogen panels creates a dangerously incomplete diagnostic picture. While viral panels show an 87% positivity rate, they overlook pneumonia-causing bacteria in the vast majority of those cases. Conversely, bacterial testing misses viral co-detections in 88% of instances. This diagnostic blind spot persists despite symptoms like fever and cough appearing identical regardless of the underlying pathogen type.
Seegene Challenges Virus-Only Testing Standards in Pediatrics
Seventy-eight percent of viral respiratory infections in children involve hidden bacterial pathogens, a gap that traditional testing often fails to bridge. Seegene is now launching the Global Million Clinical Study to push for a shift toward comprehensive syndromic PCR testing, arguing that current methods frequently miss critical co-infections.
Seegene’s data suggests that current global testing demand remains skewed, with 80% of volume focused on viral detection alone. By utilizing its STAgora statistical platform, the company aims to demonstrate that comprehensive testing—which flags multiple pathogens in a single specimen—offers a 96% positivity rate, with 82% of those results confirming the presence of at least two distinct pathogens. The upcoming Global Million Clinical Study seeks to codify these findings into a new standard for clinical practice, moving away from narrow diagnostics toward a more holistic view of respiratory illness in young patients.
Comments (0)
No comments yet. Be the first!